• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Carestream’s Vue Motion Cleared for Mobile Reading

Article

Carestream Health received FDA clearance for use of its Vue Motion image view for clinical X-ray reading on mobile devices.

The approval covers reading - not just viewing - on iPhone 4s, iPad 2, Galaxy Note and Galaxy S III mobile devices, the company announced.

“Diagnostic review of X-ray images with mobile devices can expedite patient treatment decisions and enable better collaboration, which can ultimately help enhance patient care,” Neville Skudowitz, Carestream’s global product director for healthcare information solutions, said in a statement.

Carestream recommends that during diagnostic image review, radiology professions frequently and concurrently use Vue Motion viewing tools, such as zoom, pan, and window level adjustments. This will help maximize image contrast and detail sharpness of each image displayed using Vue Motion on portable and mobile devices, according to the company.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.